Tandem Diabetes Care, Inc. (NASDAQ:TNDM) COO Purchases $190,948.56 in Stock

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) COO Jean-Claude Kyrillos acquired 10,538 shares of the company’s stock in a transaction dated Friday, March 7th. The stock was acquired at an average cost of $18.12 per share, for a total transaction of $190,948.56. Following the completion of the purchase, the chief operating officer now directly owns 10,538 shares in the company, valued at $190,948.56. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Tandem Diabetes Care Stock Performance

Shares of Tandem Diabetes Care stock opened at $18.77 on Thursday. The company has a market cap of $1.25 billion, a PE ratio of -9.73 and a beta of 1.45. The company has a quick ratio of 2.32, a current ratio of 2.90 and a debt-to-equity ratio of 1.29. Tandem Diabetes Care, Inc. has a 52 week low of $17.64 and a 52 week high of $53.69. The business has a 50 day moving average price of $32.09 and a 200-day moving average price of $34.98.

Analyst Upgrades and Downgrades

TNDM has been the subject of a number of research analyst reports. Robert W. Baird lowered their target price on Tandem Diabetes Care from $37.00 to $33.00 and set a “neutral” rating for the company in a report on Thursday, February 27th. Canaccord Genuity Group reiterated a “buy” rating and set a $63.00 target price on shares of Tandem Diabetes Care in a research report on Wednesday, February 26th. Barclays cut their target price on shares of Tandem Diabetes Care from $60.00 to $53.00 and set an “overweight” rating on the stock in a research note on Friday, February 28th. Citigroup downgraded shares of Tandem Diabetes Care from a “buy” rating to a “neutral” rating and decreased their price target for the company from $35.00 to $24.00 in a research note on Tuesday, March 4th. Finally, Sanford C. Bernstein cut shares of Tandem Diabetes Care from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $35.00 to $25.00 in a research report on Friday, February 28th. Eight investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Tandem Diabetes Care has an average rating of “Moderate Buy” and a consensus price target of $45.38.

Institutional Investors Weigh In On Tandem Diabetes Care

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Assetmark Inc. purchased a new stake in shares of Tandem Diabetes Care in the third quarter valued at about $29,000. Crossmark Global Holdings Inc. bought a new stake in Tandem Diabetes Care in the 3rd quarter worth about $200,000. State of New Jersey Common Pension Fund D increased its stake in Tandem Diabetes Care by 24.6% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 44,776 shares of the medical device company’s stock valued at $1,899,000 after buying an additional 8,837 shares during the last quarter. Los Angeles Capital Management LLC bought a new position in shares of Tandem Diabetes Care during the 3rd quarter worth approximately $263,000. Finally, Victory Capital Management Inc. boosted its stake in shares of Tandem Diabetes Care by 45.6% in the 3rd quarter. Victory Capital Management Inc. now owns 587,247 shares of the medical device company’s stock worth $24,905,000 after buying an additional 183,877 shares during the last quarter.

Tandem Diabetes Care Company Profile

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.